Lenalidomide in Myelodysplastic Syndrome and Multiple Myeloma

被引：0
|
作者：
Sachin R. Shah
Thu M. Tran
机构：
[1] Texas Tech University Health Sciences Center-School of Pharmacy/VA North Texas Health Care System,
[2] Huntsman Cancer Hospital,undefined
来源：
Drugs | 2007年 / 67卷
关键词：
Multiple Myeloma; Thalidomide; Bortezomib; Lenalidomide; Decitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The use of thalidomide is limited by adverse effects of sedation, constipation, neuropathy and thromboembolism. In order to discover more potent and less toxic immunomodulators than thalidomide, its chemical structure was modified and lenalidomide was formed.
引用
收藏
页码：1869 / 1881
页数：12
相关论文
共 50 条
  • [31] Eosinophilia During Lenalidomide Therapy in Myelodysplastic Syndrome
    Sasaki, Koji
    Kantarjian, Hagop
    Montalban-Bravo, Guillermo
    Hammond, Danielle
    Jabbour, Elias
    Kanagal-Shamanna, Rashmi
    Chien, Kelly
    Garcia-Manero, Guillermo
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (09): : 629 - 633
  • [32] Lenalidomide in the treatment of multiple myeloma: a review
    Armoiry, X.
    Aulagner, G.
    Facon, T.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (03) : 219 - 226
  • [33] Continued treatment with lenalidomide in multiple myeloma
    Sánchez J.M.
    [J]. Advances in Therapy, 2011, 28 (Suppl 8) : 1 - 13
  • [34] Lenalidomide use in multiple myeloma (Review)
    Zhang, Chao-Wei
    Wang, Ya-Nan
    Ge, Xue-Ling
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (01)
  • [35] Mechanism of Lenalidomide Activity in Multiple Myeloma
    Kroenke, Jan
    [J]. BLOOD, 2014, 124 (21)
  • [36] Lenalidomide: a new therapy for multiple myeloma
    Sonneveld, Pieter
    Palumbo, Antonio
    [J]. EJHP PRACTICE, 2008, 14 (06): : 58 - 61
  • [37] Lenalidomide use in multiple myeloma.
    Meade, Denise
    Ng, Marie
    Alford, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Continuous therapy with lenalidomide in multiple myeloma
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (01) : 10 - 10
  • [39] Lenalidomide plus dexamethasone in multiple myeloma
    Das, Manjulika
    [J]. LANCET ONCOLOGY, 2018, 19 (01): : E12 - E12
  • [40] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Dimopoulos, M. A.
    Oriol, A.
    Nahi, H.
    San-Miguel, J.
    Bahlis, N. J.
    Usmani, S. Z.
    Rabin, N.
    Orlowski, R. Z.
    Komarnicki, M.
    Suzuki, K.
    Plesner, T.
    Yoon, S. -S.
    Ben Yehuda, D.
    Richardson, P. G.
    Goldschmidt, H.
    Reece, D.
    Lisby, S.
    Khokhar, N. Z.
    O'Rourke, L.
    Chiu, C.
    Qin, X.
    Guckert, M.
    Ahmadi, T.
    Moreau, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14): : 1319 - 1331
12345